LYNCH DANIEL 4
4 · SpringWorks Therapeutics, Inc. · Filed Feb 19, 2025
Insider Transaction Report
Form 4
LYNCH DANIEL
Director
Transactions
- Sale
Common Stock
2025-02-14$60.00/sh−400$24,000→ 130,544 total
Footnotes (1)
- [F1]The sales reported on this Form 4 were effected pursuant to a trading plan pursuant to Rule 10b5-1 under the Securities Exchange Act of 1934, as amended, adopted on May 3, 2024.